DE69511240D1 - Derivate des hydroxamsäure als metalloproteinaseinhibitoren - Google Patents
Derivate des hydroxamsäure als metalloproteinaseinhibitorenInfo
- Publication number
- DE69511240D1 DE69511240D1 DE69511240T DE69511240T DE69511240D1 DE 69511240 D1 DE69511240 D1 DE 69511240D1 DE 69511240 T DE69511240 T DE 69511240T DE 69511240 T DE69511240 T DE 69511240T DE 69511240 D1 DE69511240 D1 DE 69511240D1
- Authority
- DE
- Germany
- Prior art keywords
- metalloproteinas
- inhibitors
- derivatives
- hydroxamic acid
- hydroxamic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9401129A GB9401129D0 (en) | 1994-01-21 | 1994-01-21 | Hydroxamic acid derivatives as metalloproteinase inhibitors |
PCT/GB1995/000120 WO1995019957A1 (en) | 1994-01-21 | 1995-01-23 | Hydroxamic acid derivatives as metalloproteinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69511240D1 true DE69511240D1 (de) | 1999-09-09 |
DE69511240T2 DE69511240T2 (de) | 1999-12-09 |
Family
ID=10749121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69511240T Expired - Fee Related DE69511240T2 (de) | 1994-01-21 | 1995-01-23 | Derivate des hydroxamsäure als metalloproteinaseinhibitoren |
Country Status (7)
Country | Link |
---|---|
US (1) | US5861436A (de) |
EP (1) | EP0740653B1 (de) |
JP (1) | JPH09508115A (de) |
DE (1) | DE69511240T2 (de) |
ES (1) | ES2133727T3 (de) |
GB (1) | GB9401129D0 (de) |
WO (1) | WO1995019957A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3827324B2 (ja) * | 1994-01-22 | 2006-09-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
GB9601042D0 (en) * | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Medical use |
GB9414157D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Medical use |
AU711804B2 (en) | 1995-11-23 | 1999-10-21 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US7608262B2 (en) * | 1996-02-16 | 2009-10-27 | The Kennedy Institute Of Rheumatology | Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
BR9712019A (pt) | 1996-09-10 | 1999-08-24 | British Biotech Pharm | Derivados de cidos hirox-mico citoest ticos |
EP0897908A1 (de) * | 1997-08-19 | 1999-02-24 | Roche Diagnostics GmbH | 3-Aryl-Succinamido-Hydroxamsäuren, Prozesse zu ihrer Herstellung und diese Substanzen enthaltende Medikamente |
CA2325741C (en) | 1998-03-26 | 2007-05-08 | Santen Pharmaceutical Co., Ltd. | Urea derivatives having tnf- .alpha. production inhibitory effects |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
CA2339525A1 (en) | 1998-08-05 | 2000-02-17 | Santen Pharmaceutical Co., Ltd. | Novel urea derivatives having nitrogen aromatic heterocycle |
CN1342078A (zh) * | 1999-01-13 | 2002-03-27 | 朱马制药有限公司 | 3-异噁唑烷酮及羟氨酸用于治疗感染的用途 |
GB9901863D0 (en) * | 1999-01-29 | 1999-03-17 | British Biotech Pharm | Antibacterial agents |
US6696456B1 (en) * | 1999-10-14 | 2004-02-24 | The Procter & Gamble Company | Beta disubstituted metalloprotease inhibitors |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
IL151250A0 (en) * | 2000-03-21 | 2003-04-10 | Procter & Gamble | Difluorobutyric acid metalloprotease inhibitors |
WO2001070682A2 (en) * | 2000-03-21 | 2001-09-27 | The Procter & Gamble Company | Carbocyclic side chain containing metalloprotease inhibitors |
BR0109328A (pt) * | 2000-03-21 | 2003-06-10 | Procter & Gamble | Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica |
US7098226B2 (en) * | 2000-05-31 | 2006-08-29 | Santen Pharmaceutical Co., Ltd. | TNF-α production inhibitors |
US20040192658A1 (en) * | 2002-12-27 | 2004-09-30 | Angiotech International Ag | Compositions and methods of using collajolie |
JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
JP2006517960A (ja) * | 2003-02-18 | 2006-08-03 | ファイザー インコーポレイテッド | C型肝炎ウイルスの阻害剤、それを使用する組成物および治療法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL122359C (de) * | 1964-03-06 | |||
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
US5310121A (en) * | 1992-07-24 | 1994-05-10 | Consilium Bulk Babcock Atlanta, Inc. | Cold weather bulk stacker/reclaimer apparatus and method |
JP3827324B2 (ja) * | 1994-01-22 | 2006-09-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
-
1994
- 1994-01-21 GB GB9401129A patent/GB9401129D0/en active Pending
-
1995
- 1995-01-23 WO PCT/GB1995/000120 patent/WO1995019957A1/en active IP Right Grant
- 1995-01-23 DE DE69511240T patent/DE69511240T2/de not_active Expired - Fee Related
- 1995-01-23 EP EP95906402A patent/EP0740653B1/de not_active Expired - Lifetime
- 1995-01-23 ES ES95906402T patent/ES2133727T3/es not_active Expired - Lifetime
- 1995-01-23 JP JP7519423A patent/JPH09508115A/ja active Pending
-
1997
- 1997-04-29 US US08/841,079 patent/US5861436A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0740653A1 (de) | 1996-11-06 |
DE69511240T2 (de) | 1999-12-09 |
GB9401129D0 (en) | 1994-03-16 |
EP0740653B1 (de) | 1999-08-04 |
US5861436A (en) | 1999-01-19 |
WO1995019957A1 (en) | 1995-07-27 |
ES2133727T3 (es) | 1999-09-16 |
JPH09508115A (ja) | 1997-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69511240T2 (de) | Derivate des hydroxamsäure als metalloproteinaseinhibitoren | |
DE69519751T2 (de) | Arylsulfonamido-substituierte hydroxamsäure derivate als inhibitoren von mmp und tnf | |
ATE325791T1 (de) | Hydroxypipecolate-hydroxamsäure-derivative als mmp inhibitoren | |
DE69820906D1 (de) | Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren | |
PT1070069E (pt) | Derivados biciclicos do acido hidroxamico | |
ATE263147T1 (de) | Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren | |
DE69621830T2 (de) | Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase-inhibitoren | |
NO993836D0 (no) | Arylsulfonyl-hydroksamsyre-derivater | |
DE69813616D1 (de) | Cyclohexencarboxylate als inhibitoren der neuraminidase | |
NO993730L (no) | Arylsulfonylamino-hydroksamsyrederivater | |
DE69725465D1 (de) | 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren | |
PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
DE69315662D1 (de) | Aminderivate als Korrosionsinhibitoren | |
FI971784A (fi) | Apolipoproteiini B-synteesin estäjiä | |
ATE279397T1 (de) | Phtalazine derivate phosphodiesterase 4 inhibitoren | |
EE04241B1 (et) | Apolipoproteiin-B sünteesi inhibiitorid | |
ATE240943T1 (de) | Isochinolin derivate als urokinase inhibitoren | |
EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
EE03745B1 (et) | Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena | |
DE69526475T2 (de) | 5-Alphareduktase-Inhibitoren | |
DE60012303D1 (de) | Alkinylische hydroxamsäureverbindungen als tace inhibitoren | |
DE69802692D1 (de) | Derivate der chinoloncarbonsäure | |
ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi | |
EE9600160A (et) | Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel | |
EE9600127A (et) | Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |